CCL3 and atherosclerosis: Activated platelets, neutrophils, and mast cells can release this chemokine, and neutrophils stimulated by tumor necrosis factor-alpha respond to CCL3, contributing to atherosclerosis overall by upregulating the integrins CD11b and CD18 [18,19,20].